Guardant Health Inc. (GH)
NASDAQ: GH
· Real-Time Price · USD
37.15
-2.82 (-7.06%)
At close: May 21, 2025, 3:59 PM
37.00
-0.40%
After-hours: May 21, 2025, 07:54 PM EDT
Guardant Health Revenue Breakdown
| Period Ending | Dec 31, 2024 |
|---|---|
| Reportable Segment Revenue | 739.02M |
| Reportable Segment Revenue Growth | n/a |
Operating Expense Breakdown
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 151.27M | 156.64M | 147.01M | 122.33M | 119.08M | 116.79M | 105.11M | 112.56M | 116.57M | 119.31M | 121.49M | 117.28M | 105.7M | 99.87M | 100.28M | 96.09M | 102.27M | 100.79M | 91.39M | 62.2M | 44.9M | 41.15M | 35.24M | 32.88M | 30.47M | 29.66M | 21.59M | 20.57M | 17.83M | 18.35M | 23.9M | 14.6M | 13.51M |
| Selling, General, and Administrative Revenue Growth | -3.43% | +6.55% | +20.17% | +2.73% | +1.96% | +11.12% | -6.62% | -3.44% | -2.30% | -1.79% | +3.59% | +10.96% | +5.83% | -0.41% | +4.36% | -6.04% | +1.47% | +10.29% | +46.93% | +38.53% | +9.12% | +16.75% | +7.19% | +7.91% | +2.72% | +37.36% | +4.96% | +15.37% | -2.83% | -23.23% | +63.67% | +8.10% | n/a |
| Research and Development Revenue | 88.52M | 93.54M | 87.31M | 83.1M | 83.8M | 89.86M | 93.85M | 90.36M | 93.13M | 106.58M | 100.02M | 85.45M | 81.76M | 73.02M | 70.97M | 63.72M | 55.51M | 40.28M | 36.24M | 36.32M | 37.02M | 25.88M | 24.57M | 19.53M | 16.32M | 16.65M | 14.25M | 11.55M | 8.26M | 8.12M | 7.25M | 5.97M | 5.34M |
| Research and Development Revenue Growth | -5.37% | +7.14% | +5.06% | -0.84% | -6.74% | -4.26% | +3.86% | -2.97% | -12.62% | +6.56% | +17.04% | +4.52% | +11.96% | +2.89% | +11.37% | +14.80% | +37.80% | +11.14% | -0.20% | -1.88% | +43.06% | +5.32% | +25.79% | +19.71% | -2.02% | +16.83% | +23.36% | +39.96% | +1.66% | +12.06% | +21.27% | +11.89% | n/a |
| Sales and Marketing Revenue | 104.32M | 104.76M | 97.88M | 81.87M | 80.42M | 79.13M | 68.93M | 71.04M | 76.12M | 81.42M | 80.37M | 73.6M | 64.43M | 59.6M | 50.23M | 47.72M | 34.34M | 31.29M | 25.09M | 25.02M | 25.11M | 22.29M | 18.8M | 19.44M | 17.81M | 17.11M | 13.46M | 11.57M | 11.31M | 9.56M | 7.81M | 7.93M | 7.57M |
| Sales and Marketing Revenue Growth | -0.43% | +7.03% | +19.56% | +1.79% | +1.64% | +14.79% | -2.97% | -6.67% | -6.51% | +1.31% | +9.19% | +14.23% | +8.11% | +18.66% | +5.26% | +38.96% | +9.75% | +24.68% | +0.32% | -0.40% | +12.69% | +18.54% | -3.28% | +9.16% | +4.05% | +27.11% | +16.32% | +2.32% | +18.38% | +22.39% | -1.53% | +4.79% | n/a |